Moda-flx for Home Hemodialysis
End-Stage Renal Disease (ESRD) on stable dialysis regimens
IDE Clinical TrialActive
Key Facts
Indication
End-Stage Renal Disease (ESRD) on stable dialysis regimens
Phase
IDE Clinical Trial
Status
Active
Company
About Diality
Diality, founded in 2018 and based in Irvine, California, is a private medical device company developing the Moda-flx Hemodialysis System. The platform received FDA clearance for professional care settings in August 2024 and is currently undergoing a home-use clinical trial (PRESCRIBE Diality) under an IDE. The company aims to address the burden of dialysis care by offering a versatile, easy-to-use system that supports personalized prescriptions and data-driven decision-making, targeting both clinic and home hemodialysis markets.
View full company profile